Arikace Improves MAC Lung Disease Outcomes in New Trial | 2026 Approval Path
For people living with macrolide-resistant Mycobacterium avium complex (MAC) lung disease, a chronic and often debilitating infection, recent hope is emerging. Results from the Phase 3b … Read more